Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 1, 2010, Pages 56-63

  Norata, G D ^a,b   Baragetti, I ^c   Raselli, S ^b   Stucchi, A ^c   Garlaschelli, K ^b   Vettoretti, S ^c   Piloni, G ^a   Buccianti, G ^d   Catapano, A L ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale Bassini   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d ASPREMARE Associazione Prevenzione e Terapie Malattie Renali   (Italy)

Author keywords

Adiponectin; Chronic kidney disease; Inflammation; Intima media thickness

Indexed keywords

ADIPONECTIN; ADIPONECTIN, HUMAN; BIOLOGICAL MARKER; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AGING; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENETICS; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; CREATININE; FEMALE; GENE EXPRESSION PROFILING; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 72649086073     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.01.011     Document Type: Article

References (27)

1. Becker B., Kronenberg F., Kielstein J.T., Haller H., Morath C., Ritz E., et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 16 (2005) 1091-1098
2. Iwashima Y., Horio T., Kumada M., Suzuki Y., Kihara S., Rakugi H., et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol 98 (2006) 1603-1608
3. Sharma K., Ramachandrarao S., Qiu G., Usui H.K., Zhu Y., Dunn S.R., et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118 (2008) 1645-1656
4. Zoccali C. Cardiovascular risk in uraemic patients - is it fully explained by classical risk factors?. Nephrol Dial Transplant 15 (2000) 454-457
5. Guebre-Egziabher F., Bernhard J., Funahashi T., Hadj-Aissa A., and Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 20 (2005) 129-134
6. Zoccali C., Mallamaci F., Tripepi G., Benedetto F.A., Cutrupi S., Parlongo S., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
7. Zoccali C., Mallamaci F., Panuccio V., Tripepi G., Cutrupi S., Parlongo S., et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl (2003) S98-S102
8. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
9. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
10. Menon V., Li L., Wang X., Greene T., Balakrishnan V., Madero M., et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17 (2006) 2599-2606
11. Chudek J., Adamczak M., Karkoszka H., Budzinski G., Ignacy W., Funahashi T., et al. Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc 35 (2003) 2186-2189
12. Shen Y.Y., Charlesworth J.A., Kelly J.J., Loi K.W., and Peake P.W. Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant 22 (2007) 171-178
13. Norata G.D., Ongari M., Garlaschelli K., Tibolla G., Grigore L., Raselli S., et al. Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. J Intern Med 262 (2007) 104-112
14. Norata G.D., Garlaschelli K., Ongari M., Raselli S., Grigore L., and Catapano A.L. Effects of fractalkine receptor variants on common carotid artery intima-media thickness. Stroke 37 (2006) 1558-1561
15. Norata G.D., Ongari M., Garlaschelli K., Raselli S., Grigore L., and Catapano A.L. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 156 (2007) 279-284
16. Norata G.D., Garlaschelli K., Ongari M., Raselli S., Grigore L., Benvenuto F., et al. Effect of the toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med 258 (2005) 21-27
17. Norata G.D., Raselli S., Grigore L., Garlaschelli K., Dozio E., Magni P., et al. Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 38 (2007) 2844-2846
18. Norata G.D., Grigore L., Raselli S., Redaelli L., Hamsten A., Maggi F., et al. Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies. Atherosclerosis 193 (2007) 321-327
19. Norata G.D., Marchesi P., Pirillo A., Uboldi P., Chiesa G., Maina V., et al. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol (2008)
20. Zhu W., Cheng K.K., Vanhoutte P.M., Lam K.S., and Xu A. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 114 (2008) 361-374
21. Koshimura J., Fujita H., Narita T., Shimotomai T., Hosoba M., Yoshioka N., et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun 316 (2004) 165-169
22. Fujita H., Morii T., Koshimura J., Ishikawa M., Kato M., Miura T., et al. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy. Endocr J 53 (2006) 745-752
23. Marchlewska A., Stenvinkel P., Lindholm B., Danielsson A., Pecoits-Filho R., Lonnqvist F., et al. Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. Kidney Int 66 (2004) 46-50
24. Kollerits B., Fliser D., Heid I.M., Ritz E., and Kronenberg F. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int 71 (2007) 1279-1286
25. Tsatsanis C., Zacharioudaki V., Androulidaki A., Dermitzaki E., Charalampopoulos I., Minas V., et al. Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun 335 (2005) 1254-1263
26. Wang Y., Lam K.S., Yau M.H., and Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 409 (2008) 623-633
27. Devaraj S., Swarbrick M.M., Singh U., Adams-Huet B., Havel P.J., and Jialal I. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers. Am J Clin Pathol 129 (2008) 815-822